GB1239354A - - Google Patents

Info

Publication number
GB1239354A
GB1239354A GB1239354DA GB1239354A GB 1239354 A GB1239354 A GB 1239354A GB 1239354D A GB1239354D A GB 1239354DA GB 1239354 A GB1239354 A GB 1239354A
Authority
GB
United Kingdom
Prior art keywords
antigen
ribonucleic acid
immune ribonucleic
antiserum
pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1239354A publication Critical patent/GB1239354A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1239354D 1969-02-05 1970-01-29 Expired GB1239354A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP44008533A JPS4934804B1 (cg-RX-API-DMAC10.html) 1969-02-05 1969-02-05

Publications (1)

Publication Number Publication Date
GB1239354A true GB1239354A (cg-RX-API-DMAC10.html) 1971-07-14

Family

ID=11695770

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1239354D Expired GB1239354A (cg-RX-API-DMAC10.html) 1969-02-05 1970-01-29

Country Status (4)

Country Link
JP (1) JPS4934804B1 (cg-RX-API-DMAC10.html)
DE (1) DE2004869C2 (cg-RX-API-DMAC10.html)
FR (1) FR2051489B1 (cg-RX-API-DMAC10.html)
GB (1) GB1239354A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101843902B (zh) * 2010-05-21 2012-03-07 成都军区疾病预防控制中心军事医学研究所 一种中国陆生常见蝰科蛇毒多价抗血清的制备方法及用法

Also Published As

Publication number Publication date
JPS4934804B1 (cg-RX-API-DMAC10.html) 1974-09-18
FR2051489B1 (cg-RX-API-DMAC10.html) 1974-07-12
FR2051489A1 (cg-RX-API-DMAC10.html) 1971-04-09
DE2004869C2 (de) 1982-04-22
DE2004869A1 (de) 1970-12-03

Similar Documents

Publication Publication Date Title
FI103122B1 (fi) Menetelmä muutetun pneumolysiinin valmistamiseksi
GB1422973A (en) Process for preparing adsorbed vaccines
GB1218277A (en) Dry water-dispersible aluminium hydroxide gels
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
GB1492596A (en) Tetanus toxoid and process for its manufacture
ES8107025A1 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
US3178350A (en) Biologic antigens adjuvanted with a colloidally water-soluble polymer of acrylic acidcrosslinked with polyallyl sucrose or polyallyl pentaerythritol
EP0339668A3 (en) Hepatitis a virus antigen
Iwasaki et al. Communications: Effect of Lymphocytosis-Promoting Factor (LPF) on the Appearance of Antibodies in Mice Infected with Influenza Virus
Olitzki et al. Immunological studies on bovine leptospirosis
GB1234121A (cg-RX-API-DMAC10.html)
SE7901565L (sv) Medel for immunisering
Beveridge et al. Suppression of antigenicity of influenza virus by admixture with homologous antiserum.
Audibert et al. Of antigens, adjuvants, and carriers in synthetic vaccines.
Nagano et al. Enhancement of endotoxin-induced virus-inhibiting factor or interferon production by pretreatment of the rabbit with Newcastle disease virus
GB1058340A (en) Transmissible gastroenteritis vaccines and method of producing the same
Behrens Agglutinin Production, Frequency of Injections Varied, Dosage and Total Amount Injected Constant
NZ205491A (en) Live bovine viral diarrhoea (bvd) virus vaccine, viral strain and preparation of strain
Dunlap et al. Vaccination response in rabbits related to quantity of vaccinia virus particles and passage level
Krueger et al. Use of mice model to establish effectiveness of inactivated Bordetella bronchiseptica vaccines.
Chen et al. Studies on Immunization against Plague: XVII. Experimental Studies on the Effectiveness of Aluminum-Hydroxide-Adsorbed Formalin-Killed Pasteurella pestis
March et al. Technique for volume production of mouse ascites fluid containing Bordetella pertussis antibody
Hegyessy et al. A Study of the Immunity against Tetanus Toxin following the Use of a Combined Typhoidtetanus Vaccine
DE3582422D1 (de) Biologische zubereitungen.
Mirehamsy et al. Experimental Study of Interference Between Pertussis Antigens and Salk Poliomyelitis Vaccine

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee